Verition Fund Management »

Aligos Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $664k 71k 9.32

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Warner Bros Discovery Com Ser A (WBD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Electronic Arts (EA)
Ishares Tr Russell 2000 Etf (IWM)
Palantir Technologies Cl A (PLTR)
Micron Technology (MU)

View all positions for Verition Fund Management

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Woodline Partners
Marshall Wace
Vanguard Group
Adage Capital Partners GP
Renaissance Technologies
Baker Bros. Advisors
Hillhouse Capital Advisors
Verition Fund Management
LPL Financial
Geode Capital Management
Two Sigma Investments
Jane Street

View all funds holding Aligos Therapeutics